Skip to main content

Advertisement

Table 1 Main clinical characteristics of the 19 study patients with aortic coarctation compared with 38 controls matched for cardiovascular risk factors and 38 patients with rheumatoid arthritis

From: Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study

Variables Aortic coarctation (19 patients) Controls (38 patients) RA (38 patients)
Clinical
Age (years) 33 ± 12 35 ± 14 37 ± 6
Female gender (%) 37 32 48
Body mass index (Kg/m2) 23.9 ± 4.0 26.8 ± 4.4 24.2 ± 4.2
Obesity (%) 11 17 9
Hypertension (%) 58 65 41
Dyslipidemia (%) 5 5 15
Active smoker (%) 21 12 28
Diabetes (%) 5 5 3
Systolic blood pressure (mmHg) 127 ± 17 131 ± 19 125 ± 16
Diastolic blood pressure (mmHg) 77 ± 9 83 ± 10 82 ± 10
Heart rate (beats/minute) 68 ± 12 71 ± 14 76 ± 10
Laboratory
Glycemia (mg/dl) 93 ± 9 98 ± 10 93 ± 9
Hemoglobin (gr/dl) 13.8 ± 1.6 14.6 ± 1.7 14.0 ± 1.2
GFR (ml/min/1.73m2) 105 ± 26 103 ± 20 108 ± 26
Pharmacological treatment
Betablockers (%) 32 22 8 # §
ACEi / ARB (%) 32 52 12 # §
Diuretics (%) 16 30 3 # §
Calcium antagonists (%) 11 35 3 # §
Anti-platelets agents (%) 0 1 4
Statins (%) 0 1 1
  1. ACEi Angiotensin-converting enzyme inhibitors, ARB Angiotensin T1 receptor blockers, GFR Glomerular Filtration Rate, RA rheumatoir arthritis
  2. # = p < 0.05 rheumatoid arthritis (RA) vs coarctation
  3. § = p < 0.05 RA vs controls